Magnetar Financial LLC Global Blood Therapeutics, Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $26.9 Million - $56.6 Million	829,531 New	829,531 $56.5 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $420,198 - $705,533	-8,623 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $231,045 - $482,913	5,538 Added 179.51%	8,623 $441,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $140,984 - $252,538	3,085 New	3,085 $245,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $1.36 Million - $1.74 Million	-30,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.58 Million - $1.9 Million	30,000 New	30,000 $1.58 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.